InvestorsHub Logo
Followers 0
Posts 34
Boards Moderated 0
Alias Born 03/28/2014

Re: DewDiligence post# 12216

Monday, 07/28/2014 4:52:17 PM

Monday, July 28, 2014 4:52:17 PM

Post# of 20689
Dew regarding your rough estimates of MNTA/NVS possibly attaining $420mm of annual Copaxone sales given ANDA approval for MNTA/NVS .... do you assign or have an estimate on margins. If I remember correctly, with NVS this is a 50/50 profit split?